ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.72
0.56%
US Tech 100
17,632.40
0.17%
S&P 500
5,213.19
0.49%
US Dollar vs CAD
1.3676
-0.38%
Bitcoin
62,417.09
2.01%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Precigen Inc (PGEN)

  7. Precigen Inc (PGEN) News

PGEN

Precigen (PGEN)

Precigen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PGEN
DateTimeSourceHeadlineSymbolCompany
05/08/20243:05PMPR Newswire (US)Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual MeetingNASDAQ:PGENPrecigen Inc
04/24/20249:20AMPR Newswire (US)Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual MeetingNASDAQ:PGENPrecigen Inc
04/24/20248:00AMPR Newswire (US)Actym Therapeutics Appoints Thomas Smart as CEONASDAQ:PGENPrecigen Inc
03/28/20243:05PMPR Newswire (US)Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11thNASDAQ:PGENPrecigen Inc
03/19/20243:05PMPR Newswire (US)Precigen Reports Full Year 2023 Financial Results and Business UpdatesNASDAQ:PGENPrecigen Inc
03/19/20246:27AMIH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:PGENPrecigen Inc
03/12/20243:05PMPR Newswire (US)Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory PapillomatosisNASDAQ:PGENPrecigen Inc
03/05/20243:05PMPR Newswire (US)Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19thNASDAQ:PGENPrecigen Inc
02/27/202412:48PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PGENPrecigen Inc
02/14/20243:00PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PGENPrecigen Inc
02/14/20242:20PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PGENPrecigen Inc
02/08/20243:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
02/06/20243:05PMPR Newswire (US)Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:PGENPrecigen Inc
01/17/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PGENPrecigen Inc
01/16/20247:05AMPR Newswire (US)Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European CommissionNASDAQ:PGENPrecigen Inc
01/08/20247:39AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
01/08/20247:30AMPR Newswire (US)Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PGENPrecigen Inc
12/29/20234:26PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PGENPrecigen Inc
12/18/20233:05PMPR Newswire (US)Precigen to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PGENPrecigen Inc
11/29/20233:05PMPR Newswire (US)Precigen to Participate in the JMP Securities Hematology and Oncology SummitNASDAQ:PGENPrecigen Inc
11/09/20234:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PGENPrecigen Inc
11/09/20234:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
11/09/20233:55PMPR Newswire (US)Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical ProgramsNASDAQ:PGENPrecigen Inc
11/07/20233:05PMPR Newswire (US)Precigen to Participate in the Stifel 2023 Healthcare ConferenceNASDAQ:PGENPrecigen Inc
09/19/20233:05PMPR Newswire (US)Precigen to Participate in Upcoming Leading Investor and Industry ConferencesNASDAQ:PGENPrecigen Inc
08/25/20236:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
08/25/20236:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
08/25/20236:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
08/25/20236:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
08/25/20235:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
 Showing the most relevant articles for your search:NASDAQ:PGEN

Your Recent History

USOTC
BMXI
Brookmount Explorations (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
RDAR
Raadr (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
ECSL
Ecare Solutions (PK)
NASDAQ
HOLO
MicroCloud Hologram
USOTC
INQD
Indoor Harvest (PK)
USOTC
KGKG
Kona Gold Beverage (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
KEGS
1812 Brewing (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
FLES
Auto Parts 4Less (PK)
USOTC
TKMO
Tekumo (PK)
USOTC
BABL
Buildablock (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved